267 related articles for article (PubMed ID: 10571515)
21. CA125 expression in epithelioid sarcoma.
Kato H; Hatori M; Kokubun S; Watanabe M; Smith RA; Hotta T; Ogose A; Morita T; Murakami T; Aiba S
Jpn J Clin Oncol; 2004 Mar; 34(3):149-54. PubMed ID: 15078911
[TBL] [Abstract][Full Text] [Related]
22. Down-regulated E-cadherin expression is associated with poor five-year overall survival in bone and soft tissue sarcoma: results of a meta-analysis.
Wang N; He YL; Pang LJ; Zou H; Liu CX; Zhao J; Hu JM; Zhang WJ; Qi Y; Li F
PLoS One; 2015; 10(3):e0121448. PubMed ID: 25822802
[TBL] [Abstract][Full Text] [Related]
23. Altered expression of cell cycle regulatory proteins in benign and malignant bone and soft tissue neoplasms.
Bui MM; Bagui TK; Boulware DC; Letson DG; Nasir A; Kaiser HE; Pledger WJ; Coppola D
In Vivo; 2007; 21(5):729-37. PubMed ID: 18019405
[TBL] [Abstract][Full Text] [Related]
24. Utility of the immunohistochemical detection of FLI-1 expression in round cell and vascular neoplasm using a monoclonal antibody.
Rossi S; Orvieto E; Furlanetto A; Laurino L; Ninfo V; Dei Tos AP
Mod Pathol; 2004 May; 17(5):547-52. PubMed ID: 15001993
[TBL] [Abstract][Full Text] [Related]
25. TLE1 expression is not specific for synovial sarcoma: a whole section study of 163 soft tissue and bone neoplasms.
Kosemehmetoglu K; Vrana JA; Folpe AL
Mod Pathol; 2009 Jul; 22(7):872-8. PubMed ID: 19363472
[TBL] [Abstract][Full Text] [Related]
26. Myogenic regulatory protein expression in adult soft tissue sarcomas. A sensitive and specific marker of skeletal muscle differentiation.
Tallini G; Parham DM; Dias P; Cordon-Cardo C; Houghton PJ; Rosai J
Am J Pathol; 1994 Apr; 144(4):693-701. PubMed ID: 8160771
[TBL] [Abstract][Full Text] [Related]
27. Molecular and immunohistochemical identification of p53 alterations in bone and soft tissue sarcomas.
Mousses S; McAuley L; Bell RS; Kandel R; Andrulis IL
Mod Pathol; 1996 Jan; 9(1):1-6. PubMed ID: 8821948
[TBL] [Abstract][Full Text] [Related]
28. Radiation-associated synovial sarcoma: clinicopathologic and molecular analysis of two cases.
Egger JF; Coindre JM; Benhattar J; Coucke P; Guillou L
Mod Pathol; 2002 Sep; 15(9):998-1004. PubMed ID: 12218218
[TBL] [Abstract][Full Text] [Related]
29. High-level expression of podoplanin in benign and malignant soft tissue tumors: immunohistochemical and quantitative real-time RT-PCR analysis.
Xu Y; Ogose A; Kawashima H; Hotta T; Ariizumi T; Li G; Umezu H; Endo N
Oncol Rep; 2011 Mar; 25(3):599-607. PubMed ID: 21234520
[TBL] [Abstract][Full Text] [Related]
30. Cytogenetic analysis of 46 pleomorphic soft tissue sarcomas and correlation with morphologic and clinical features: a report of the CHAMP Study Group. Chromosomes and MorPhology.
Mertens F; Fletcher CD; Dal Cin P; De Wever I; Mandahl N; Mitelman F; Rosai J; Rydholm A; Sciot R; Tallini G; Van den Berghe H; Vanni R; Willén H
Genes Chromosomes Cancer; 1998 May; 22(1):16-25. PubMed ID: 9591630
[TBL] [Abstract][Full Text] [Related]
31. Heterologous and rare homologous sarcomas of the uterine corpus: a clinicopathologic review.
Fadare O
Adv Anat Pathol; 2011 Jan; 18(1):60-74. PubMed ID: 21169739
[TBL] [Abstract][Full Text] [Related]
32. [Imprint cytological features of soft tissue sarcomas].
Sonobe H
Rinsho Byori; 1999 Jul; 47(7):614-21. PubMed ID: 10442039
[TBL] [Abstract][Full Text] [Related]
33. SATB2 is a novel marker of osteoblastic differentiation in bone and soft tissue tumours.
Conner JR; Hornick JL
Histopathology; 2013 Jul; 63(1):36-49. PubMed ID: 23701429
[TBL] [Abstract][Full Text] [Related]
34. Expression of E-cadherin and p53 proteins in human soft tissue sarcomas.
Yoo J; Park S; Kang CS; Kang SJ; Kim BK
Arch Pathol Lab Med; 2002 Jan; 126(1):33-8. PubMed ID: 11800644
[TBL] [Abstract][Full Text] [Related]
35. Dysadherin expression as a significant prognostic factor and as a determinant of histologic features in synovial sarcoma: special reference to its inverse relationship with E-cadherin expression.
Izumi T; Oda Y; Hasegawa T; Nakanishi Y; Kawai A; Sonobe H; Takahira T; Kobayashi C; Yamamoto H; Tamiya S; Hirohashi S; Iwamoto Y; Tsuneyoshi M
Am J Surg Pathol; 2007 Jan; 31(1):85-94. PubMed ID: 17197923
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical analysis of Fas ligand expression in sarcomas. Sarcomas express high level of FasL in vivo.
Lee SH; Jang JJ; Lee JY; Kim SY; Park WS; Kim CS; Kim SH; Yoo NJ
APMIS; 1998 Nov; 106(11):1035-40. PubMed ID: 9890264
[TBL] [Abstract][Full Text] [Related]
37. LHRH receptor expression in sarcomas of bone and soft tissue.
Deivaraju C; Temple HT; Block N; Robinson P; Schally AV
Horm Mol Biol Clin Investig; 2016 Nov; 28(2):105-111. PubMed ID: 27639272
[TBL] [Abstract][Full Text] [Related]
38. NY-ESO-1 (CTAG1B) expression in mesenchymal tumors.
Endo M; de Graaff MA; Ingram DR; Lim S; Lev DC; Briaire-de Bruijn IH; Somaiah N; Bovée JV; Lazar AJ; Nielsen TO
Mod Pathol; 2015 Apr; 28(4):587-95. PubMed ID: 25412843
[TBL] [Abstract][Full Text] [Related]
39. Bone and soft tissue sarcomas in cerebrospinal fluid and effusion: A 20-year review at our institution.
Sharma A; Thangaiah JJ; Shetty S; Policarpio-Nicolas MLC
Cancer Cytopathol; 2021 Oct; 129(10):776-787. PubMed ID: 34233079
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical staining for KIT (CD117) in soft tissue sarcomas is very limited in distribution.
Hornick JL; Fletcher CD
Am J Clin Pathol; 2002 Feb; 117(2):188-93. PubMed ID: 11865845
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
